Search for: "Advanced Clinical LLC" Results 1 - 20 of 239
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jan 2015, 4:34 pm by Sabrina I. Pacifici
News release: “Johnson & Johnson today announced that its subsidiary, Janssen Research and Development, LLC, has entered into a novel agreement with Yale School of Medicine’s Open Data Access (YODA) Project that will extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. [read post]
11 Jan 2017, 10:50 am
Shire Pharmaceuticals LLC and other subsidiaries of Shire plc (Shire) will pay $350 million to settle federal and state False Claims Act allegations that Shire and Advanced BioHealing (ABH) — a company it acquired in 2011 — employed kickbacks and other unlawful methods to induce clinics and physicians to use or overuse its product “Dermagraft,” a... [read post]
11 Jan 2017, 10:50 am
Shire Pharmaceuticals LLC and other subsidiaries of Shire plc (Shire) will pay $350 million to settle federal and state False Claims Act allegations that Shire and Advanced BioHealing (ABH) — a company it acquired in 2011 — employed kickbacks and other unlawful methods to induce clinics and physicians to use or overuse its product “Dermagraft,” a... [read post]
22 Oct 2009, 10:19 am by Lebowitz & Mzhen
Our attorneys at Lebowitz and Mzhen, LLC, have recently read a study on nursing home residents with advanced dementia, published in the October 15, 2009, issue of The New England Journal of Medicine. [read post]
30 Aug 2023, 11:17 am by Unknown
Among the awards is a $12.4 million grant to support Regenerative Patch Technologies LLC in a Phase 2b clinical trial to evaluate the safety and efficacy of a retinal pigmented epithelial (RPE) implant. [read post]
23 Jul 2014, 7:33 am by Joy Waltemath
A female employee at a medical clinic who reported multiple instances of verbal harassment from a male patient advanced her hostile work environment claim, a federal district court in Hawaii ruled. [read post]
31 Oct 2018, 5:45 am by Jennifer Brand
Shagin Member, The Shagin Law Group, LLC Adjunct Professor of Law, Widener Commonwealth Law School    Rebecca Sharpless Professor of Clinical Legal Education, University of Miami School of Law   William A. [read post]
19 Jan 2017, 10:37 am by admin
Central to the allegation was the contention that Shire and Advanced BioHealing (ABH) (a company Shire Plc acquired in 2011) , used kickbacks as part of its scheme to induce clinics and physicians to use or overprescribe its product “Dermagraft,” (a bioengineered human skin substitute) for the treatment of diabetic foot ulcers. [read post]
19 Jan 2017, 10:37 am by admin
Central to the allegation was the contention that Shire and Advanced BioHealing (ABH) (a company Shire Plc acquired in 2011) , used kickbacks as part of its scheme to induce clinics and physicians to use or overprescribe its product “Dermagraft,” (a bioengineered human skin substitute) for the treatment of diabetic foot ulcers. [read post]
15 Mar 2012, 6:42 pm by Thaddeus Mason Pope, J.D., Ph.D.
Panelists include Ed Holland, Coordinator of Hospice Spiritual Care & Grief Support, Park Nicollet Methodist Hospice April Boxeth, Attorney, Voigt, Rode, & Boxeth, LLC Vic Sandler, MD, Fairview Hospice Medical Director Mary Schroeder, Clinical Manager Advance Care Planning & Community Palliative Care, Allina Home and Community Services Jennifer L. [read post]
27 May 2009, 3:50 pm by Lebowitz & Mzhen
In that year, The Montgomery County Health Information Exchange Collaborative began a pilot program that linked community hospitals, the county’s health department, and area health clinics. [read post]
23 Mar 2012, 5:37 pm by Thaddeus Mason Pope, J.D., Ph.D.
Panelists include Ed Holland, Coordinator of Hospice Spiritual Care & Grief Support, Park Nicollet Methodist Hospice; April Boxeth, Attorney, Voigt, Rode, & Boxeth, LLC; Vic Sandler, MD, Fairview Hospice Medical Director; and Mary Schroeder, Clinical Manager Advance Care Planning & Community Palliative Care, Allina Home and Community Services. [read post]
7 Aug 2012, 9:59 pm by Linda Moss
On Monday Pfizer said that  the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in J&J’s Janssen Alzheimer Immunotherapy R&D LLC -led Phase 3 trial of intravenous bapineuzumab in patients with mild-to-moderate Alzheimer’s disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype, which is a marker for the disease. [read post]